Search

Your search keyword '"Ogawa, Yuji"' showing total 698 results
Start Over Author "Ogawa, Yuji"
698 results on '"Ogawa, Yuji"'

1. Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH

Author

Imajo, Kento, Saigusa, Yusuke, Kobayashi, Takashi, Nagai, Koki, Nishida, Shinya, Kawamura, Nobuyoshi, Doi, Hiroyoshi, Iwaki, Michihiro, Nogami, Asako, Honda, Yasushi, Kessoku, Takaomi, Ogawa, Yuji, Kirikoshi, Hiroyuki, Kokubu, Shigehiro, Utsunomiya, Daisuke, Takahashi, Hirokazu, Aishima, Shinichi, Sumida, Yoshio, Saito, Satoru, Yoneda, Masato, Dennis, Andrea, Kin, Stella, Andersson, Anneli, and Nakajima, Atsushi

Published
2024
Full Text
View/download PDF

3. M‐PAST score is better than MAST score for the diagnosis of active fibrotic nonalcoholic steatohepatitis

Author

Imajo, Kento, Saigusa, Yusuke, Kobayashi, Takashi, Nagai, Koki, Nishida, Shinya, Kawamura, Nobuyoshi, Doi, Hiroyoshi, Iwaki, Michihiro, Nogami, Asako, Honda, Yasushi, Kessoku, Takaomi, Ogawa, Yuji, Kirikoshi, Hiroyuki, Yasuda, Satoshi, Toyoda, Hidenori, Hayashi, Hideki, Kokubu, Shigehiro, Utsunomiya, Daisuke, Takahashi, Hirokazu, Aishima, Shinichi, Kim, Beom Kyung, Tamaki, Nobuharu, Saito, Satoru, Yoneda, Masato, Loomba, Rohit, and Nakajima, Atsushi

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Liver Disease, Biomedical Imaging, Hepatitis, Chronic Liver Disease and Cirrhosis, Digestive Diseases, Clinical Research, 4.2 Evaluation of markers and technologies, Oral and gastrointestinal, active fibrotic NASH, F-CAST, FAST, M-PAST, MAST
Abstract

BackgroundClinical trials enroll patients with active fibrotic nonalcoholic steatohepatitis (NASH) (nonalcoholic fatty liver disease [NAFLD] activity score ≥ 4) and significant fibrosis (F ≥ 2); however, screening failure rates are high following biopsy. We developed new scores to identify active fibrotic NASH using FibroScan and magnetic resonance imaging (MRI).MethodsWe undertook prospective primary (n = 176), retrospective validation (n = 169), and University of California San Diego (UCSD; n = 234) studies of liver biopsy-proven NAFLD. Liver stiffness measurement (LSM) using FibroScan or magnetic resonance elastography (MRE), controlled attenuation parameter (CAP), or proton density fat fraction (PDFF), and aspartate aminotransferase (AST) were combined to develop a two-step strategy-FibroScan-based LSM followed by CAP with AST (F-CAST) and MRE-based LSM followed by PDFF with AST (M-PAST)-and compared with FibroScan-AST (FAST) and MRI-AST (MAST) for diagnosing active fibrotic NASH. Each model was categorized using rule-in and rule-out criteria.ResultsAreas under receiver operating characteristic curves (AUROCs) of F-CAST (0.826) and M-PAST (0.832) were significantly higher than those of FAST (0.744, p = 0.004) and MAST (0.710, p

Published
2023

6. Distribution of Fibrosis‐4 index and vibration‐controlled transient elastography‐derived liver stiffness measurement for patients with metabolic dysfunction‐associated steatotic liver disease in health check‐up.

Author

Ogawa, Yuji, Tomeno, Wataru, Imamura, Yasushi, Baba, Masaru, Ueno, Takato, Kobayashi, Takashi, Iwaki, Michihiro, Nogami, Asako, Kessoku, Takaomi, Honda, Yasushi, Notsumata, Kazuo, Fujikawa, Hirotoshi, Kaai, Megumi, Imajo, Kento, Kawanaka, Miwa, Hyogo, Hideyuki, Hisatomi, Mitsurou, Takeuchi, Mamiko, Hakamada, Taku, and Honda, Takashi

Subjects
*HEPATIC fibrosis, *NONINVASIVE diagnostic tests, *LIVER diseases, *METABOLIC disorders, *MEDICAL screening
Abstract

Aims Methods Results Conclusions The multisociety consensus nomenclature has introduced steatotic liver disease (SLD) with diverse subclassifications, which are metabolic dysfunction‐associated steatotic liver disease (MASLD), metabolic dysfunction and alcohol‐associated steatotic liver disease (MetALD), alcohol‐associated liver disease (ALD), specific etiology, and cryptogenic. We investigated their prevalence, as per the new definition, in individuals undergoing health check‐ups. Additionally, we analyzed the distribution of Fibrosis‐4 (FIB‐4) index and vibration‐controlled transient elastography (VCTE)‐derived liver stiffness measurement (LSM) for MASLD.In this cross‐sectional study, 6530 subjects undergoing a health check‐up in Japan were included. Conventional B‐mode ultrasound was carried out on all 6530 subjects, and those with MASLD underwent VCTE.The prevalence of SLD was 39.5%, comprising MASLD 28.7%, MetALD 8.6%, ALD 1.2%, specific etiology SLD 0.3%, and cryptogenic SLD 0.7%. Subjects with VCTE‐derived LSM ≥8 kPa constituted 2.1% of MASLD. FIB‐4 ≥1.3 showed that the sensitivity, specificity, positive predictive value (PPV), and negative predictive value for diagnosing VCTE‐derived LSM ≥8 kPa were 60.6%, 77.0%, 5.3%, and 98.9%, respectively. The referral rate to specialists was 23.8% using FIB‐4 ≥1.30. “FIB‐4 ≥1.3 in subjects <65 years and FIB‐4 ≥2.0 in subjects ≥65 years” showed higher PPV (6.7%) and lower referral rate (17.1%) compared with FIB‐4 ≥1.3, but the sensitivity (54.5%) did not show adequate diagnostic capability as a noninvasive test for diagnosing VCTE‐derived LSM ≥8 kPa.Acknowledging the selection bias in hepatology centers, we undertook this prospective health check‐up study. Although the FIB‐4 index proves to be a convenient marker, it might not perform well as a primary screening tool for liver fibrosis in the general population (UMIN Clinical Trials Registry No. UMIN000035188). [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

11. WED-283 The distribution of fibrosis-4 index and vibration-controlled transient elastography-derived liver stiffness measurement for patients with metabolic dysfunction associated steatotic liver disease in the general population

Author

Ogawa, Yuji, primary, Tomeno, Wataru, additional, Yasushi, Imamura, additional, Baba, Masaru, additional, Ueno, Takato, additional, Kobayashi, Takashi, additional, Iwaki, Michihiro, additional, Nogami, Asako, additional, Kessoku, Takaomi, additional, Honda, Yasushi, additional, Imajo, Kento, additional, Kawanaka, Miwa, additional, Hisatomi, Mitsurou, additional, Takeuchi, Mamiko, additional, Honda, Takashi, additional, Tatsuta, Miwa, additional, Morishita, Asahiro, additional, Mikami, Shigeru, additional, Furuya, Ken, additional, Manabe, Noriaki, additional, Kamada, Tomoari, additional, Kawaguchi, Takumi, additional, Yoneda, Masato, additional, Saito, Satoru, additional, and Nakajima, Atsushi, additional

Published
2024
Full Text
View/download PDF

13. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan

Author

Yoneda, Masato, Yamamoto, Takuma, Honda, Yasushi, Imajo, Kento, Ogawa, Yuji, Kessoku, Takaomi, Kobayashi, Takashi, Nogami, Asako, Higurashi, Takuma, Kato, Shingo, Hosono, Kunihiro, Saito, Satoru, and Nakajima, Atsushi

Published
2021
Full Text
View/download PDF

15. Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial

Author

Kessoku, Takaomi, Imajo, Kento, Kobayashi, Takashi, Ozaki, Anna, Iwaki, Michihiro, Honda, Yasushi, Kato, Takayuki, Ogawa, Yuji, Tomeno, Wataru, Kato, Shingo, Higurashi, Takuma, Yoneda, Masato, Kirikoshi, Hiroyuki, Kubota, Kazumi, Taguri, Masataka, Yamanaka, Takeharu, Usuda, Haruki, Wada, Koichiro, Kobayashi, Noritoshi, Saito, Satoru, and Nakajima, Atsushi

Published
2020
Full Text
View/download PDF

17. Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational Study

Author

Kasai, Yuki, Kessoku, Takaomi, Tanaka, Kosuke, Yamamoto, Atsushi, Takahashi, Kota, Kobayashi, Takashi, Iwaki, Michihiro, Ozaki, Anna, Nogami, Asako, Honda, Yasushi, Ogawa, Yuji, Kato, Shingo, Imajo, Kento, Higurashi, Takuma, Hosono, Kunihiro, Yoneda, Masato, Usuda, Haruki, Wada, Koichiro, Kawanaka, Miwa, Kawaguchi, Takumi, Torimura, Takuji, Kage, Masayoshi, Hyogo, Hideyuki, Takahashi, Hirokazu, Eguchi, Yuichiro, Aishima, Shinichi, Kobayashi, Noritoshi, Sumida, Yoshio, Honda, Akira, Oyamada, Shunsuke, Shinoda, Satoru, Saito, Satoru, and Nakajima, Atsushi

Published
2022
Full Text
View/download PDF

18. MAXI observations of GRBs

Author

Serino, Motoko, Sakamoto, Takanori, Kawai, Nobuyuki, Yoshida, Atsumasa, Ohno, Masanori, Ogawa, Yuji, Nishimura, Yasunori, Fukushima, Kosuke, Higa, Masaya, Ishikawa, Kazuto, Ishikawa, Masaki, Kawamuro, Taiki, Kimura, Masashi, Matsuoka, Masaru, Mihara, Tatehiro, Morii, Mikio, Nakagawa, Yujin E., Nakahira, Satoshi, Nakajima, Motoki, Nakano, Yuki, Negoro, Hitoshi, Onodera, Takuya, Sasaki, Masayuki, Shidatsu, Megumi, Sugimoto, Juri, Sugizaki, Mutsumi, Suwa, Fumitoshi, Suzuki, Kazuhiko, Tachibana, Yutaro, Takagi, Toshihiro, Toizumi, Takahiro, Tomida, Hiroshi, Tsuboi, Yohko, Tsunemi, Hiroshi, Ueda, Yoshihiro, Ueno, Shiro, Usui, Ryuichi, Yamada, Hisaki, Yamamoto, Takayuki, Yamaoka, Kazutaka, Yamauchi, Makoto, Yoshidome, Koshiro, and Yoshii, Taketoshi

Subjects
Astrophysics - High Energy Astrophysical Phenomena
Abstract

Monitor of all-sky image (MAXI) Gas Slit Camera (GSC) detects gamma-ray bursts (GRBs) including the bursts with soft spectra, such as X-ray flashes (XRFs). MAXI/GSC is sensitive to the energy range from 2 to 30 keV. This energy range is lower than other currently operating instruments which is capable of detecting GRBs. Since the beginning of the MAXI operation on August 15, 2009, GSC observed 35 GRBs up to the middle of 2013. One third of them are also observed by other satellites. The rest of them show a trend to have soft spectra and low fluxes. Because of the contribution of those XRFs, the MAXI GRB rate is about three times higher than those expected from the BATSE log N - log P distribution. When we compare it to the observational results of the Wide-field X-ray Monitor on the High Energy Transient Explorer 2, which covers the the same energy range to that of MAXI/GSC, we find a possibility that many of MAXI bursts are XRFs with Epeak lower than 20 keV. We discuss the source of soft GRBs observed only by MAXI. The MAXI log N - log S distribution suggests that the MAXI XRFs distribute in closer distance than hard GRBs. Since the distributions of the hardness of galactic stellar flares and X-ray bursts overlap with those of MAXI GRBs, we discuss a possibility of a confusion of those galactic transients with the MAXI GRB samples., Comment: 12 figures

Published
2014
Full Text
View/download PDF

20. Accuracy of liver stiffness measurement and controlled attenuation parameter using FibroScan® M/XL probes to diagnose liver fibrosis and steatosis in patients with nonalcoholic fatty liver disease: a multicenter prospective study

Author

Oeda, Satoshi, Takahashi, Hirokazu, Imajo, Kento, Seko, Yuya, Ogawa, Yuji, Moriguchi, Michihisa, Yoneda, Masato, Anzai, Keizo, Aishima, Shinichi, Kage, Masayoshi, Itoh, Yoshito, Nakajima, Atsushi, and Eguchi, Yuichiro

Published
2020
Full Text
View/download PDF

21. The 37-month MAXI/GSC source catalog in the high Galactic-latitude sky

Author

Hiroi, Kazuo, Ueda, Yoshihiro, Hayashida, Masaaki, Shidatsu, Megumi, Sato, Ryosuke, Kawamuro, Taiki, Sugizaki, Mutsumi, Nakahira, Satoshi, Serino, Motoko, Kawai, Nobuyuki, Matsuoka, Masaru, Mihara, Tatehiro, Morii, Mikio, Nakajima, Motoki, Negoro, Hitoshi, Sakamoto, Takanori, Tomida, Hiroshi, Tsuboi, Yohko, Tsunemi, Hiroshi, Ueno, Shiro, Yamaoka, Kazutaka, Yoshida, Atsumasa, Asada, Masato, Eguchi, Satoshi, Hanayama, Takanori, Higa, Masaya, Ishikawa, Kazuto, Ishikawa, Masaki, Isobe, Naoki, Kohama, Mitsuhiro, Kimura, Masashi, Morihana, Kumiko, Nakagawa, Yujin E., Nakano, Yuki, Nishimura, Yasunori, Ogawa, Yuji, Sasaki, Masayuki, Sugimoto, Juri, Takagi, Toshihiro, Usui, Ryuichi, Yamamoto, Takayuki, Yamauchi, Makoto, and Yoshidome, Koshiro

Subjects
Astrophysics - High Energy Astrophysical Phenomena
Abstract

We present the catalog of high Galactic-latitude ($|b|>10^{\circ}$) X-ray sources detected in the first 37-month data of Monitor of All-sky X-ray Image (MAXI) / Gas Slit Camera (GSC). To achieve the best sensitivity, we develop a background model of the GSC that well reproduces the data based on the detailed on-board calibration. Source detection is performed through image fit with the Poisson likelihood algorithm. The catalog contains 500 objects detected in the 4--10 keV band with significance of $s_{\rm D, 4-10 keV} \geq 7$. The limiting sensitivity is $\approx 7.5\times10^{-12}$ ergs cm$^{-2}$ s$^{-1}$ ($\approx 0.6$ mCrab) in the 4--10 keV band for 50% of the survey area, which is the highest ever achieved as an all-sky survey mission covering this energy band. We summarize the statistical properties of the catalog and results from cross matching with the Swift/BAT 70-month catalog, the meta-catalog of X-ray detected clusters of galaxies, and the MAXI/GSC 7-month catalog. Our catalog lists the source name (2MAXI), position and its error, detection significances and fluxes in the 4--10 keV and 3--4 keV bands, their hardness ratio, and basic information of the likely counterpart available for 296 sources., Comment: 21 pages, 15 figures, 3 tables, accepted for publication in ApJS

Published
2013
Full Text
View/download PDF

22. Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease

Author

Iwaki, Michihiro, primary, Kessoku, Takaomi, additional, Tanaka, Kosuke, additional, Ozaki, Anna, additional, Kasai, Yuki, additional, Kobayashi, Takashi, additional, Nogami, Asako, additional, Honda, Yasushi, additional, Ogawa, Yuji, additional, Imajo, Kento, additional, Usuda, Haruki, additional, Wada, Koichiro, additional, Kobayashi, Noritoshi, additional, Saito, Satoru, additional, Nakajima, Atsushi, additional, and Yoneda, Masato, additional

Published
2023
Full Text
View/download PDF

23. Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography

Author

Kobayashi, Takashi, primary, Iwaki, Michihiro, additional, Nogami, Asako, additional, Kawamura, Nobuyoshi, additional, Honda, Yasushi, additional, Ogawa, Yuji, additional, Imajo, Kento, additional, Yoneda, Masato, additional, Saito, Satoru, additional, and Nakajima, Atsushi, additional

Published
2023
Full Text
View/download PDF

24. Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design

Author

Kessoku, Takaomi, Imajo, Kento, Kobayashi, Takashi, Honda, Yasushi, Kato, Takayuki, Ogawa, Yuji, Tomeno, Wataru, Kato, Shingo, Higurashi, Takuma, Yoneda, Masato, Kirikoshi, Hiroyuki, Kubota, Kazumi, Taguri, Masataka, Yamanaka, Takeharu, Usuda, Haruki, Wada, Koichiro, Saito, Satoru, and Nakajima, Atsushi

Published
2018
Full Text
View/download PDF

25. Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study

Author

Ozaki, Anna, Kessoku, Takaomi, Iwaki, Michihiro, Kobayashi, Takashi, Yoshihara, Tsutomu, Kato, Takayuki, Honda, Yasushi, Ogawa, Yuji, Imajo, Kento, Higurashi, Takuma, Yoneda, Masato, Taguri, Masataka, Yamanaka, Takeharu, Ishiki, Hiroto, Kobayashi, Noritoshi, Saito, Satoru, Ichikawa, Yasushi, and Nakajima, Atsushi

Published
2020
Full Text
View/download PDF

26. Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib.

Author

Saruta, Masayuki, Kawaguchi, Isao, Ogawa, Yuji, Sanchez Gonzalez, Yuri, Numajiri, Naoki, Tang, Xiaohe, and Miller, Russell

Abstract

Aim: Patients with moderately to severely active ulcerative colitis have an increasing number of advanced therapy options including several biologics and Janus kinase inhibitors. Though data on efficacy and safety of these advanced therapies are available, less is known about the potential economic implications of their utilization in Japan. We evaluated the relative value of these advanced therapies in Japan using a locally developed cost per responder model. Methods: A model was developed using relevant clinical endpoints and treatment costs to calculate cost per responder of all advanced therapies used for moderately to severely active ulcerative colitis treatment in Japan. Cost per responder was assessed in biologic-naïve and biologic-exposed populations, respectively. The model incorporated induction and maintenance therapy pathways as patients progressed through based on efficacy rates (clinical response, clinical remission and endoscopic improvement). Total costs for induction and maintenance included: drug acquisition, drug administration and serious adverse event management (as necessary) for responders, with additional rescue treatment cost only for non-responders. Results: Upadacitinib showed lower cost per clinical response and cost per clinical remission across both biologic-naïve and biologic-exposed populations with only one exemption in cost per clinical remission in biologic-naïve population. In addition, upadacitinib demonstrated lower cost per endoscopic improvement in both populations. Janus kinase inhibitors outperformed with lower cost per responder than other mediations across all outcomes and patient populations with the exception of tofacitinib for clinical remission in biologic-exposed UC population. Limitations: Comparative data used in this analysis have been derived from network meta-analysis, not from direct comparison. Conclusions: The results of this cost per responder analysis suggest upadacitinib is a cost-effective option for the first- and second-line treatment of moderately to severely active ulcerative colitis in Japan. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

28. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

Author

Imajo, Kento, Kessoku, Takaomi, Honda, Yasushi, Tomeno, Wataru, Ogawa, Yuji, Mawatari, Hironori, Fujita, Koji, Yoneda, Masato, Taguri, Masataka, Hyogo, Hideyuki, Sumida, Yoshio, Ono, Masafumi, Eguchi, Yuichiro, Inoue, Tomio, Yamanaka, Takeharu, Wada, Koichiro, Saito, Satoru, and Nakajima, Atsushi

Published
2016
Full Text
View/download PDF

33. An Experimental Environment for Analyzing Collaborative Learning Interaction

Author

Hayashi, Yuki, Ogawa, Yuji, Nakano, Yukiko I., Hutchison, David, editor, Kanade, Takeo, editor, Kittler, Josef, editor, Kleinberg, Jon M., editor, Mattern, Friedemann, editor, Mitchell, John C., editor, Naor, Moni, editor, Nierstrasz, Oscar, editor, Pandu Rangan, C., editor, Steffen, Bernhard, editor, Sudan, Madhu, editor, Terzopoulos, Demetri, editor, Tygar, Doug, editor, Vardi, Moshe Y., editor, Weikum, Gerhard, editor, and Yamamoto, Sakae, editor

Published
2013
Full Text
View/download PDF

34. Real‐world assessment of SmartExam, a novel FibroScan computational method: A retrospective single‐center cohort study

Author

Nogami, Asako, primary, Iwaki, Michihiro, additional, Kobayashi, Takashi, additional, Honda, Yasushi, additional, Ogawa, Yuji, additional, Imajo, Kento, additional, Higurashi, Takuma, additional, Hosono, Kunihiro, additional, Kirikoshi, Hiroyuki, additional, Saito, Satoru, additional, Nakajima, Atsushi, additional, and Yoneda, Masato, additional

Published
2022
Full Text
View/download PDF

35. Meta‐analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease

Author

Honda, Yasushi, primary, Yoneda, Masato, additional, Kobayashi, Takashi, additional, Iwaki, Michihiro, additional, Kawamura, Nobuyoshi, additional, Nogami, Asako, additional, Kessoku, Takaomi, additional, Ogawa, Yuji, additional, Tomeno, Wataru, additional, Imajo, Kento, additional, Horita, Nobuyuki, additional, Saito, Satoru, additional, Kaneko, Takeshi, additional, and Nakajima, Atsushi, additional

Published
2022
Full Text
View/download PDF

40. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey

Author

Tokushige, Katsutoshi, Hyogo, Hideyuki, Nakajima, Tomoaki, Ono, Masafumi, Kawaguchi, Takumi, Honda, Koichi, Eguchi, Yuichiro, Nozaki, Yuichi, Kawanaka, Miwa, Tanaka, Saiyu, Imajo, Kento, Sumida, Yoshio, Kamada, Yoshihiro, Fujii, Hideki, Suzuki, Yasuaki, Kogiso, Tomomi, Karino, Yoshiyasu, Munekage, Kensuke, Kuromatsu, Ryoko, Oeda, Satoshi, Yanase, Mikio, Mori, Kohjiro, Ogawa, Yuji, Seko, Yuya, Takehara, Tetsuo, Itoh, Yoshito, Nakajima, Atsushi, Kanemasa, Kazuyuki, Nishino, Ken, Masaki, Naohiko, Takahashi, Hirokazu, Seike, Masataka, Torimura, Takuji, Saibara, Toshiji, Toyota, Joji, Chayama, Kazuaki, and Hashimoto, Etsuko

Published
2016
Full Text
View/download PDF

41. Comparison of long‐term prognosis between non‐obese and obese patients with non‐alcoholic fatty liver disease

Author

Iwaki, Michihiro, primary, Kessoku, Takaomi, additional, Tanaka, Kosuke, additional, Ozaki, Anna, additional, Kasai, Yuki, additional, Yamamoto, Atsushi, additional, Takahashi, Kota, additional, Kobayashi, Takashi, additional, Nogami, Asako, additional, Honda, Yasushi, additional, Ogawa, Yuji, additional, Imajo, Kento, additional, Oyamada, Shunsuke, additional, Kobayashi, Noritoshi, additional, Aishima, Shinichi, additional, Saito, Satoru, additional, Nakajima, Atsushi, additional, and Yoneda, Masato, additional

Published
2022
Full Text
View/download PDF

42. Characterization of Nutrient Intake in Biopsy-Confirmed NAFLD Patients

Author

Kamada, Yoshihiro, primary, Takahashi, Hirokazu, additional, Ogawa, Yuji, additional, Hyogo, Hideyuki, additional, Nakamura, Kyoko, additional, Yada, Tomomi, additional, Asada, Norihiko, additional, Bando, Tomomi, additional, Sawano, Hanako, additional, Hatanaka, Mika, additional, Tosa, Takako, additional, Ando, Mika, additional, Hikita, Etsuko, additional, Yoshida, Kaori, additional, Koseki, Masahiro, additional, Sumida, Yoshio, additional, Maeda, Kazuhisa, additional, Fujii, Makoto, additional, Aishima, Shinichi, additional, Hayakawa, Mariko, additional, and Nakajima, Atsushi, additional

Published
2022
Full Text
View/download PDF

43. New scoring system using MRI with AST for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis

Author

Imajo, Kento, primary, Saigusa, Yusuke, additional, Kobayashi, Takashi, additional, Nagai, Koki, additional, Nishida, Shinya, additional, Kawamura, Nobuyoshi, additional, Iwaki, Michihiro, additional, Honda, Yasushi, additional, Kessoku, Takaomi, additional, Ogawa, Yuji, additional, Kirikoshi, Hiroyuki, additional, Yasuda, Satoshi, additional, Toyoda, Hidenori, additional, Hayashi, Hideki, additional, Doi, Hiroyoshi, additional, Kokubu, Shigehiro, additional, Utsunomiya, Daisuke, additional, Takahashi, Hirokazu, additional, Aishima, Shinichi, additional, Saito, Satoru, additional, Yoneda, Masato, additional, and Nakajima, Atsushi, additional

Published
2022
Full Text
View/download PDF

44. Efficacy and safety of guanabenz acetate treatment for non-alcoholic fatty liver disease: a study protocol for a randomised investigator-initiated phase IIa study

Author

Iwaki, Michihiro, primary, Kessoku, Takaomi, additional, Tanaka, Kosuke, additional, Ozaki, Anna, additional, Kasai, Yuki, additional, Yamamoto, Atsushi, additional, Takahashi, Kota, additional, Kobayashi, Takashi, additional, Nogami, Asako, additional, Honda, Yasushi, additional, Ogawa, Yuji, additional, Imajo, Kento, additional, Yoneda, Masato, additional, Kobayashi, Noritoshi, additional, Saito, Satoru, additional, and Nakajima, Atsushi, additional

Published
2022
Full Text
View/download PDF

48. A meta-analysis of the diagnostic accuracy of type Ⅳ collagen 7S for the staging of liver fibrosis in NAFLD

Author

Honda, Yasushi, primary, Yoneda, Masato, additional, Kobayashi, Takashi, additional, Iwaki, Michihiro, additional, Kawamura, Nobuyoshi, additional, Nogami, Asako, additional, Kessoku, Takaomi, additional, Ogawa, Yuji, additional, Tomeno, Wataru, additional, Imajo, Kento, additional, Horita, Nobuyuki, additional, Saito, Satoru, additional, Kaneko, Takeshi, additional, and Nakajima, Atsushi, additional

Published
2022
Full Text
View/download PDF

49. A 3-step approach to predict advanced fibrosis in nonalcoholic fatty liver disease: Impact on diagnosis, patient burden, and medical costs

Author

Kobayashi, Takashi, primary, Ogawa, Yuji, additional, Shinoda, Satoru, additional, Iwaki, Michihiro, additional, Nogami, Asako, additional, Honda, Yasushi, additional, Kessoku, Takaomi, additional, Imajo, Kento, additional, Masato, Yoneda, additional, Saito, Satoru, additional, Yamamoto, Kouji, additional, Oeda, Satoshi, additional, Takahashi, Hirokazu, additional, Sumida, Yoshio, additional, and Nakajima, Atsushi, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results